Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹892 Cr₹1,005 Cr₹484 Cr₹766 Cr₹598 Cr

What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA is ₹892 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹892 Cr
Mar2024₹1,005 Cr
Mar2023₹484 Cr
Mar2022₹766 Cr
Mar2021₹598 Cr

How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹892 Cr
-11.17
Mar2024 ₹1,005 Cr
107.60
Mar2023 ₹484 Cr
-36.86
Mar2022 ₹766 Cr
28.25
Mar2021 ₹598 Cr -

Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,051.4 Cr 1.9% -1.3% -28% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

1.9%

-1.3%

-28%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses